-+ 0.00%
-+ 0.00%
-+ 0.00%

Changes in US stocks | Pharmaceutical stocks reversed the market and Lilai (LLY.US) rose nearly 4%

Zhitongcaijing·09/24/2026 14:49:01
Listen to the news

The Zhitong Finance App learned that on Thursday, US pharmaceutical stocks rose against the market. LLY.US (LLY.US) rose nearly 4%, with a market capitalization of about 1.12 trillion US dollars, Pfizer (PFE.US) rose more than 2%, MSD (MRK.US) and JNJ.US (JNJ.US) rose nearly 2%, Novartis Pharmaceuticals (NVS.US) and Novo Nordisk (NVO.US) rose more than 1%; the AI medical concept stock Tempus AI (TEM.US) rose nearly 5%. According to the news, Eli Lilly announced that it has signed an R&D cooperation and licensing agreement with Nuochengjianhua. The two sides will carry out strategic cooperation in the field of innovative drug research and development. Relying on a proprietary drug discovery platform and deep research experience, Nochengjianhua will discover and develop up to 5 innovative target projects to address major unmet clinical needs. According to the terms of the agreement, Eli Lilly will pay Novartis a down payment of up to $100 million and recent milestone payments. The total amount of potential R&D and commercialization milestone payments is approximately US$3.25 billion.